Skip to content

DYEVERT™ PLUS EZ HV-EZ-RRSRecalls & reported problems

Osprey Medical Inc. · DyeVert Plus EZ Contrast Reduction System. · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00815241020577), received between Nov 30, 2020 and Nov 30, 2020 — classified as 1 malfunction.

The most frequently reported specific device problem is “Loss of or Failure to Bond” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Loss of or Failure to Bond1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 30, 2020Loss of or Failure to Bond; Loss of or Failure to Bond

    DURING THE PROCEDURE, USER IDENTIFIED AIR CONTINUED TO APPEAR IN PATIENT FLUID PATHWAY OF MODULE. DEVICE WAS REMOVED AND REPLACED WITH A NEW MODULE WITH NO IMPACT TO PATIENT OR PROCEDURE. NO ADVERSE EVENTS WERE REPORTED. INVESTIGATION OF RETURNED PRODUCT IDENTIFIED A BOND GAP OF ADHESIVE BETWEEN TUBING AND HOUSING. INVESTIGATION IDENTIFIED THIS WAS AN ISOLATED MANUFACTURING ISSUE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 10922917 ↗

Other Injector And Syringe, Angiographic devices

All Injector And Syringe, Angiographic devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page